The board of directors of Pfizer Inc. today declared a 26-cent
fourth-quarter 2014 dividend on the company’s common stock, payable
December 2, 2014, to shareholders of record at the close of business on
November 7, 2014.
- Adjusted earnings per share increased 36% to $0.49; GAAP EPS totaled $0.35 versus $0.24 in the prior year quarter - Achieved 20th consecutive quarter of strong double-digit adjusted EPS growth
- Led by the Specialty Platform, all segments delivered year-over-year operating income gains driven by continued mix improvement and synergies from the Spartech acquisition CLEVELAND , Oct.
BI1181181/VTP-37948 Demonstrated Greater Than 80% Reduction of an Alzheimer's Disease Biomarker, the Cerebral Spinal Fluid Amyloid Beta Levels BI1181181/VTP-37948 Was Safe and Generally Well-Tolerated With a Profile Supporting Once-Daily Dosing
FORT WASHINGTON, Pa., Oct.
Symbol: POT Listed: TSX, NYSE Key Highlights
Earnings of $0.38 per share 1 for third-quarter 2014; nine-month total of $1.33 per share
Third-quarter cash provided by operating activities of $574 million
Higher potash sales volumes for both the quarter and first nine months
Improved potash realizations (up $18 per tonne from second-quarter 2014)
Record nine-month nitrogen gross margin of $776 million
Full-year guidance now $1.75-$1.85 per share; previous range $1.70-$1.90
SASKATOON , Oct.
POZEN Inc. (NASDAQ: POZN) , a pharmaceutical company
committed to transforming medicine that transforms lives, today
announced that it has received three patents from the United States
Patent and Trademark Office (USPTO), entitled “Pharmaceutical
Compositions for the Coordinated Delivery of NSAIDs” that cover the U.S.
approved product VIMOVO ® (naproxen / esomeprazole magnesium)
Principal Financial Group, Inc. (NYSE:PFG) announced today that its
board of directors declared a cash dividend of $1.39075 per share on its
5.563% Series A non–cumulative perpetual preferred stock and a cash
dividend of $0.407375 per share on its 6.518% Series B non-cumulative
perpetual preferred stock.
Qlik (NASDAQ: QLIK), a leader in data discovery delivering intuitive
solutions for self-service data visualization and guided analytics,
today announced financial results for the third quarter ended September
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.